Last reviewed · How we verify
NCT05124093: Apox-HFNO
The Effect of High-flow Nasal Oxygen Flow Rate on Gas Exchange During Apnoea
NA trial testing Apnoeic oxygenation in Apnea in 114 participants. Completed in 25 May 2022.
25 May 2022
Quick facts
| Lead sponsor | University College Hospital Galway |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 114 |
| Start date | 22 November 2021 |
| Primary completion | 25 May 2022 |
| Estimated completion | 25 May 2022 |
| Sites | 1 location across Ireland |
Drugs / interventions tested
- Apnoeic oxygenation
Conditions studied
- Apnea — all drugs for Apnea →
- Respiration; Arrest — all drugs for Respiration; Arrest →
- Anesthesia — all drugs for Anesthesia →
Sponsor
University College Hospital Galway
Who can join
18 and older, any sex, with Apnea or Respiration; Arrest. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Apnoeic oxygenation refers to oxygenation that occurs through the insufflation of oxygen into the lungs in the absence spontaneous respiration or positive pressure ventilation. It is used to extend the time to desaturation at induction of anaesthesia and as a primary oxygenation technique during airway surgery. The impact of high-flow nasal oxygen flow rate selection on gas exchange is poorly understood. Participants in this study will be randomised to receive a certain nasal oxygen flow rate during apnoea and its effect on gas exchange will be measured by blood gas analysis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05124093
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Apnea
Currently open trials in the same condition.
- NCT06638528 — Effects of Walking Apnea At High Lung Volume on Hypoalgesia · NA · recruiting
- NCT06659887 — Different Low Flow Rates on Gas Exchange in Children During Apnea · NA · recruiting
- NCT04950894 — Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Neurostimulation · NA · active not recruiting
- NCT04190953 — Upper Airway's Pressure Drop Analyses After Mandibular Advancement and Maxillary Expansion · NA · recruiting
Other University College Hospital Galway trials
Trials by the same sponsor.
- NCT07453498 — Evaluating the Efficacy of the Psoas Sheath Block for Post Operative Analgesia Following Hip Arthroplasty · NA · recruiting
- NCT06419153 — Evaluating the Efficacy of the Sub-psoas Fascial Plane Block for Post-operative Analgesia Following Hemiarthroplasty · not yet recruiting
- NCT05839704 — A Comparison of Two Regional Techniques for Bariatric Sleeve Gastrectomy · NA · unknown
- NCT05804565 — MetaMet: Bone Cutter Versus Bone Saw for Ray Amputation · NA · unknown
- NCT04511923 — Nebulised Heparin to Reduce COVID-19 Induced Acute Lung Injury · Phase 1, PHASE2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05124093 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University College Hospital Galway
- Last refreshed: 11 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05124093.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing